In-vitro susceptibility of Aspergillus spp. isolates to amphotericin B and itraconazole

Journal of Antimicrobial Chemotherapy

Volumn 44, Issue 4, 1999, Pages 553-555

  Dannaoui, Eric ^a   Persat, Florence ^a   Monier, Marie France ^a   Borel, Elisabeth ^a   Piens, Marie Antoinette ^a   Picot, Stéphane ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; ITRACONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLOSIS; ASPERGILLUS; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIDULANS; ASPERGILLUS NIGER; ASPERGILLUS TERREUS; HUMAN; MINIMUM INHIBITORY CONCENTRATION;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASPERGILLUS; HUMANS; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS;

EID: 0032869643     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/44.4.553     Document Type: Article

References (9)

1. Espinel-Ingroff, A., Bartlett, M., Bowden, R., Chin, N. X., Cooper, C., Fothergill, A. et al. (1997). Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi. Journal of Clinical Microbiology 35, 139-43.
2. Chryssanthou, E. (1997). In vitro susceptibility of respiratory isolates of Aspergillus species to itraconazole and amphotericin B. Acquired resistance to itraconazole. Scandinavian Journal of Infectious Diseases 29, 509-12.
3. Denning, D. W., Venkateswarlu, K., Oakley, K. L., Anderson, M. J., Manning, N. J., Stevens, D. A. et al. (1997). Itraconazole resistance in Aspergillus fumigatus. Antimicrobial Agents and Chemotherapy 41, 1364-8.
4. Denning, D. W., Radford, S. A., Oakley, K. L., Hall, L., Johnson, E. M. & Warnock, D. W. (1997). Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection. Journal of Antimicrobial Chemotherapy 40, 401-14.
5. Oakley, K. L., Moore, C. B. & Denning, D. W. (1998). In-vitro activity of voriconazole against Aspergillus spp. and comparison with ilraconazole and amphotericin B. Journal of Antimicrobial Chemotherapy 42, 91-4.
6. National Committe for Clinical Laboratory Standards. (1997). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Approved Standard M27-A. NCCLS, Wayne, PA.
7. Verweij, P. E., Oakley, K. L., Morrissey, J., Morrissey, G. & Denning, D. W. (1998). Efficacy of LY303366 against amphotericin B-susceptible and -resistant Aspergillus fumigatus in a murine model of invasive aspergillosis. Antimicrobial Agents and Chemotherapy 42, 873-8.
8. Manavathu, E. K., Alangaden, G. J. & Lerner, S. A. (1996). A comparative study of the broth micro-and macro-dilution techniques for the determination of the in vitro susceptibility of Aspergillus fumigatus. Canadian Journal of Microbiology 42, 960-4.
9. Verweij, P. E., Mensink, M., Rijs, A. J., Donnelly, J. P., Meis, J. F. & Denning, D. W. (1998). In-vitro activities of amphotericin B, itraconazole and voriconazole against 150 clinical and environmental Aspergillus fumigatus isolates. Journal of Antimicrobial Chemotherapy 42, 389-92.